Cargando…
A survey of proteomic biomarkers for heterotopic ossification in blood serum
BACKGROUND: Heterotopic ossification (HO) is a significant problem for wounded warriors surviving high-energy blast injuries; however, currently, there is no biomarker panel capable of globally characterizing, diagnosing, and monitoring HO progression. The aim of this study was to identify biomarker...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418723/ https://www.ncbi.nlm.nih.gov/pubmed/28472996 http://dx.doi.org/10.1186/s13018-017-0567-2 |
_version_ | 1783234098091786240 |
---|---|
author | Edsberg, Laura E. Crowgey, Erin L. Osborn, Patrick M. Wyffels, Jennifer T. |
author_facet | Edsberg, Laura E. Crowgey, Erin L. Osborn, Patrick M. Wyffels, Jennifer T. |
author_sort | Edsberg, Laura E. |
collection | PubMed |
description | BACKGROUND: Heterotopic ossification (HO) is a significant problem for wounded warriors surviving high-energy blast injuries; however, currently, there is no biomarker panel capable of globally characterizing, diagnosing, and monitoring HO progression. The aim of this study was to identify biomarkers for HO using proteomic techniques and blood serum. METHODS: Isobaric tags for relative and absolute quantitation (iTRAQ) was used to generate a semi-quantitative global proteomics survey of serum from patients with and without heterotopic ossification. Leveraging the iTRAQ data, a targeted selection reaction monitoring mass spectrometry (SRM-MS) assay was developed for 10 protein candidates: alkaline phosphatase, osteocalcin, alpha-2 type I collagen, collagen alpha-1(V) chain isoform 2 preprotein, bone sialoprotein 2, phosphatidate phosphatase LPIN2, osteomodulin, protein phosphatase 1J, and RRP12-like protein. RESULTS: The proteomic survey of serum from both healthy and disease patients includes 1220 proteins and was enriched for proteins involved in the response to elevated platelet Ca(+2), wound healing, and extracellular matrix organization. Proteolytic peptides from three of the ten SRM-MS proteins, osteocalcin preprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein from serum, are potential clinical biomarkers for HO. CONCLUSIONS: This study is the first reported SRM-MS analysis of serum from individuals with and without heterotopic ossification, and differences in the serum proteomic profile between healthy and diseased subjects were identified. Furthermore, our results indicate that normal wound healing signals can impact the ability to identify biomarkers, and a multi-protein panel assay, including osteocalcin preproprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein, may provide a solution for HO detection and monitoring. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13018-017-0567-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5418723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54187232017-05-08 A survey of proteomic biomarkers for heterotopic ossification in blood serum Edsberg, Laura E. Crowgey, Erin L. Osborn, Patrick M. Wyffels, Jennifer T. J Orthop Surg Res Research Article BACKGROUND: Heterotopic ossification (HO) is a significant problem for wounded warriors surviving high-energy blast injuries; however, currently, there is no biomarker panel capable of globally characterizing, diagnosing, and monitoring HO progression. The aim of this study was to identify biomarkers for HO using proteomic techniques and blood serum. METHODS: Isobaric tags for relative and absolute quantitation (iTRAQ) was used to generate a semi-quantitative global proteomics survey of serum from patients with and without heterotopic ossification. Leveraging the iTRAQ data, a targeted selection reaction monitoring mass spectrometry (SRM-MS) assay was developed for 10 protein candidates: alkaline phosphatase, osteocalcin, alpha-2 type I collagen, collagen alpha-1(V) chain isoform 2 preprotein, bone sialoprotein 2, phosphatidate phosphatase LPIN2, osteomodulin, protein phosphatase 1J, and RRP12-like protein. RESULTS: The proteomic survey of serum from both healthy and disease patients includes 1220 proteins and was enriched for proteins involved in the response to elevated platelet Ca(+2), wound healing, and extracellular matrix organization. Proteolytic peptides from three of the ten SRM-MS proteins, osteocalcin preprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein from serum, are potential clinical biomarkers for HO. CONCLUSIONS: This study is the first reported SRM-MS analysis of serum from individuals with and without heterotopic ossification, and differences in the serum proteomic profile between healthy and diseased subjects were identified. Furthermore, our results indicate that normal wound healing signals can impact the ability to identify biomarkers, and a multi-protein panel assay, including osteocalcin preproprotein, osteomodulin precursor, and collagen alpha-1(v) chain isoform 2 preprotein, may provide a solution for HO detection and monitoring. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13018-017-0567-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-04 /pmc/articles/PMC5418723/ /pubmed/28472996 http://dx.doi.org/10.1186/s13018-017-0567-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Edsberg, Laura E. Crowgey, Erin L. Osborn, Patrick M. Wyffels, Jennifer T. A survey of proteomic biomarkers for heterotopic ossification in blood serum |
title | A survey of proteomic biomarkers for heterotopic ossification in blood serum |
title_full | A survey of proteomic biomarkers for heterotopic ossification in blood serum |
title_fullStr | A survey of proteomic biomarkers for heterotopic ossification in blood serum |
title_full_unstemmed | A survey of proteomic biomarkers for heterotopic ossification in blood serum |
title_short | A survey of proteomic biomarkers for heterotopic ossification in blood serum |
title_sort | survey of proteomic biomarkers for heterotopic ossification in blood serum |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418723/ https://www.ncbi.nlm.nih.gov/pubmed/28472996 http://dx.doi.org/10.1186/s13018-017-0567-2 |
work_keys_str_mv | AT edsberglaurae asurveyofproteomicbiomarkersforheterotopicossificationinbloodserum AT crowgeyerinl asurveyofproteomicbiomarkersforheterotopicossificationinbloodserum AT osbornpatrickm asurveyofproteomicbiomarkersforheterotopicossificationinbloodserum AT wyffelsjennifert asurveyofproteomicbiomarkersforheterotopicossificationinbloodserum AT edsberglaurae surveyofproteomicbiomarkersforheterotopicossificationinbloodserum AT crowgeyerinl surveyofproteomicbiomarkersforheterotopicossificationinbloodserum AT osbornpatrickm surveyofproteomicbiomarkersforheterotopicossificationinbloodserum AT wyffelsjennifert surveyofproteomicbiomarkersforheterotopicossificationinbloodserum |